We are live on ! Find out more
BCTXW

BriaCell Therapeutics Corp Warrant
BCTXW

Delisted

BCTXW was delisted on the 26th of February, 2026.

Back to rankings

4 hedge funds and large institutions have $129K invested in BriaCell Therapeutics Corp Warrant in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4 → 4 (0)

1.74% less ownership

Funds ownership: 3% → 1.26% (-1.7%)

35% less capital invested

Capital invested by funds: $197K → $129K (-$68.1K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$7.67K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$109K – – –
RAM
2
Redmond Asset Management
Virginia
$18K – – –
UBS Group
3
UBS Group
Switzerland
$1.85K -$7.67K -22,645 -78%
Osaic Holdings
4
Osaic Holdings
Arizona
$192 – – –

BCTXW Hedge Fund Activity: Q4 2024 in Review

4 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q4 2024, worth a combined $129K — down 35% from $197K a quarter earlier.

Fund positioning in BCTXW was balanced in Q4 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was UBS Group, cutting an estimated $7.67K.

  • 4 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $129K of BriaCell Therapeutics Corp Warrant stock for Q4 2024, down 35% quarter-over-quarter.
  • 0 funds opened new BriaCell Therapeutics Corp Warrant positions in Q4 2024 and 0 closed out.
  • The largest BriaCell Therapeutics Corp Warrant seller in Q4 2024 was UBS Group, an estimated $7.67K sold.

Based on aggregated 13F filings for Q4 2024.